Anti-MLL3 / KMT2C, clone 1686CT202.60.69

In 1X PBS, pH 7.4, with 0.09% sodium azide. KMT2C (Lysine N-methyltransferase 2C), also called MML3 (Myeloid/lymphoid or mixed-lineage leukemia protein 3) is a histone methyltransferase, which means it adds methyl groups to histone proteins. This modification plays a critical role in controlling how genes are turned on and off. By regulating gene expression, KMT2C/MML3 can influence various cellular processes, including cell growth, differentiation, and death. Research has also shown that mutations in the KMT2C gene are associated with the development of certain types of cancer. For example, mutations in KMT2C have been found in breast cancer, colorectal cancer, and other types of tumors. In addition to its role in cancer, KMT2C/MML3 is also involved in DNA repair. This protein plays a crucial role in repairing damaged DNA, which is essential for maintaining genomic stability and preventing the development of genetic mutations. Protein function: Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:22266653, PubMed:24081332, PubMed:25561738). Likely plays a redundant role with KMT2D in enriching H3K4me1 mark on primed and active enhancer elements (PubMed:24081332). [The UniProt Consortium]